Article

Multiple system atrophy: genetic risks and alpha-synuclein mutations

2017-11-30

Abstract excerpt

Multiple system atrophy (MSA) is one of the few neurodegenerative disorders where we have a significant understanding of the clinical and pathological manifestations but where the aetiology remains almost completely unknown. Research to overcome this hurdle is gaining momentum through international research collaboration and a series of genetic and molecular discoveries in the last few years, which have advanced o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c7af4abc-2f54-5354-82d1-79bdf18b08a4
DOI: 10.12688/f1000research.12193.1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Multiple system atrophy: genetic risks and alpha-synuclein mutationsDOI 10.12688/f1000research.12193.1Read

Genetic players in multiple system atrophy: unfolding the nature of the beast.Semantic proximity Read

The genetic basis of multiple system atrophySemantic proximity Read

Multiple System Atrophy: Pathology, Pathogenesis, and Path ForwardSemantic proximity Read

Multiple-system atrophy: a new α-synuclein disease?Semantic proximity Read

Heterogeneity of Multiple System Atrophy: An UpdateSemantic proximity Read

α-Synucleinopathy phenotypes.Semantic proximity Read

Multiple system atrophy: the application of genetics in understanding etiology.Semantic proximity Read

Cross-examining candidate genes implicated in multiple system atrophySemantic proximity Read

Genetics of Synucleinopathies.Semantic proximity Read

Neuronal α-synuclein toxicity is the key driver of neurodegeneration in multiple system atrophySemantic proximity Read

Alpha-Synuclein Aggregation in Parkinson's DiseaseSemantic proximity Read

SynucleinopathiesSemantic proximity Read